Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by National Cancer Center, Korea.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Ji-youn Han, National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT01159327
First received: July 8, 2010
Last updated: September 15, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)